豪鵬科技(001283.SZ):下游應用覆蓋了包含AI、XR在內的各類智能穿戴類產品
格隆匯12月31日丨豪鵬科技(001283.SZ)在投資者互動平台表示,公司在消費電子電池領域深耕二十餘年,已在小軟包鋰離子電池出貨量方面位居全球前列,下游應用覆蓋了包含AI、XR在內的各類智能穿戴類產品,並與多家智能穿戴頭部品牌客户積極進行新型終端配套產品的驗證導入。公司目前是行業內領先的智能穿戴類硬件一站式電池解決方案提供商,憑藉品類多元化及細分差異化,公司已形成了獨特的技術、品牌和客户資源優勢。公司將會持續加大研發投入,滿足更多國際品牌客户需求,不斷超越自我、持續進行技術突破,為更多智能硬件落地提供更好的電池解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.